Effect of platelet lysate on the functional and molecular characteristics of mesenchymal stem cells isolated from adipose tissue

Current Stem Cell Research and Therapy

Volumn 6, Issue 2, 2011, Pages 105-114

  Castegnaro, Silvia ^a   Chieregato, Katia ^a   Maddalena, Marta ^a   Albiero, Elena ^a   Visco, Carlo ^a   Madeo, Domenico ^a   Pegoraro, Maurizio ^a   Rodeghiero, Francesco ^a  

^a SAN BORTOLO HOSPITAL   (Italy)

Author keywords

Adipose tissue; Culture medium; Mesenchymal stem cells; Platelet lysate; Stem cells

Indexed keywords

GELATINASE A; T LYMPHOCYTE ANTIGEN;

ADIPOSE TISSUE; ADULT; ARTICLE; CELL COUNT; CELL DIFFERENTIATION; CELL LYSATE; CELL PROLIFERATION; CELL SURFACE; CULTURE MEDIUM; FLOW CYTOMETRY; HUMAN; LYMPHOCYTE PROLIFERATION; MESENCHYMAL STEM CELL; NORMAL HUMAN; PRIORITY JOURNAL; RNA ISOLATION; T LYMPHOCYTE; THROMBOCYTE; THROMBOCYTE POOR PLASMA;

ADIPOSE TISSUE; ADULT; ANIMALS; BIOLOGICAL MARKERS; BLOOD PLATELETS; CATTLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; COCULTURE TECHNIQUES; COLONY-FORMING UNITS ASSAY; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; HUMANS; IMMUNOSUPPRESSION; LYMPHOCYTE ACTIVATION; MESENCHYMAL STEM CELLS; MIDDLE AGED; MULTIPOTENT STEM CELLS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PLATELET COUNT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 79955690512     PISSN: 1574888X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157488811795495440     Document Type: Article

References (42)

1. Friedenstein AJ, Petrakova KV, Kurolesova AI, Frolova GP. Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation 1968; 6(2): 230-47.
2. Pittenger MF, Mackay AM, Beck SC, et al. Multiline age potential of adult human mesenchymal stem cells. Science 1999; 284(5411):143-7.
3. Smith JR, Pochampally R, Perry A, Hsu SC, Prockop DJ. Isolationof a highly clonogenic and multipotential subfraction of adult stemcells from bone marrow stroma. Stem Cells 2004; 22(5): 823-31.
4. Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The InternationalSociety for Cellular Therapy position statement. Cytotherapy 2006;8(4): 315-7.
5. Kassem M, Kristiansen M, Abdallah BM. Mesenchymal stem cells:cell biology and potential use in therapy. Basic Clin PharmacolToxicol 2004; 95(5): 209-14.
6. Bartholomew A, Sturgeon C, Siatskas M, et al. Mesenchymal stemcells suppress lymphocyte proliferation in vitro and prolong skingraft survival in vivo. Exp Hematol 2002; 30(1): 42-8.
7. Koç ON, Gerson SL, Cooper BW, et al. Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. J Clin Oncol 2000;18(2): 307-16.
8. Le Blanc K, Ringdén O. Immunobiology of human mesenchymalstem cells and future use in hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2005; 11(5): 321-34.
9. Le Blanc K, Rasmusson I, Sundberg B, et al. Treatment of severe acute graft-versus-host disease with third party haplo identical mesenchymalstem cells. Lancet 2004; 363(9419): 1439-41.
10. Zuk PA, Zhu M, Ashjian P, et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 2002; 13(12): 4279-95.
11. Nöth U, Osyczka AM, Tuli R, Hickok NJ, Danielson KG, Tuan RS. Multiline age mesenchymal differentiation potential of human trabecular bone-derived cells. J Orthop Res 2002; 20(5): 1060-9.
12. Sakaguchi Y, Sekiya I, Yagishita K, Ichinose S, Shinomiya K, Muneta T. Suspended cells from trabecular bone by collagenase digestion become virtually identical to mesenchymal stem cells obtained from marrow aspirates. Blood 2004; 104(9): 2728-35.
13. Sarugaser R, Lickorish D, Baksh D, Hosseini MM, Davies JE. Human umbilical cord perivascular (HUCPV) cells: a source ofmesenchymal progenitors. Stem Cells 2005; 23(2): 220-9.
14. In 't Anker PS, Scherjon SA, Kleijburg-van der Keur C, et al. Isolationof mesenchymal stem cells of fetal or maternal origin fromhuman placenta. Stem Cells 2004; 22(7): 1338-45.
15. Erices A, Conget P, Minguell JJ. Mesenchymal progenitor cells inhuman umbilical cord blood. Br J Haematol 2000; 109(1): 235-42.
16. Lu LL, Liu YJ, Yang SG, et al. Isolation and characterization ofhuman umbilical cord mesenchymal stem cells with hematopoiesissupportivefunction and other potentials. Haematologica 2006;91(8): 1017-26.
17. Lee RH, Kim B, Choi I, et al. Characterization and expressionanalysis of mesenchymal stem cells from human bone marrow andadipose tissue. Cell Physiol Biochem 2004; 14(4-6): 311-24.
18. Tuschong L, Soenen SL, Blaese RM, Candotti F, Muul LM. Immune response to fetal calf serum by two adenosine deaminase deficient patients after T cell gene therapy. Hum Gene Ther 2002;13(13): 1605-10.
19. Gregory CA, Reyes E, Whitney MJ, Spees JL. Enhanced engraftmentof mesenchymal stem cells in a cutaneous wound model by culture in allogenic species-specific serum and administration in fibrin constructs. Stem Cells 2006; 24(10): 2232-43.
20. European Medicine Agency (EMEA) Guideline on human cell based medicinal product. Doc. Ref. EMEA/CHMP/410869/2006,May 2008.
21. Food and Drug Administration (FDA)/Center for Biologics Evaluation and Research (CBER). Guidance for human somatic cell therapy and gene therapy. March, 1998.
22. Weibrich G, Kleis WK, Hafner G, Hitzler WE. Growth factor levelsin platelet-rich plasma and correlations with donor age, sex, and platelet count. J Craniomaxillofac Surg 2002; 30(2): 97-102.
23. Sánchez AR, Sheridan PJ, Kupp LI. Is platelet-rich plasma theperfect enhancement factor? A current review. Int J Oral Maxillofac Implants 2003; 18(1): 93-103.
24. Kulterer B, Friedl G, Jandrositz A, et al. Gene expression profiling of human mesenchymal stem cells derived from bone marrow during expansion and osteoblast differentiation. BMC Genomics 2007;8: 70.
25. Peroni D, Scambi I, Pasini A, et al. Stem molecular signature ofadipose-derived stromal cells. Exp Cell Res 2008; 314(3): 603-15.
26. Ulloa-Montoya F, Kidder BL, Pauwelyn KA, et al. Comparativetranscriptome analysis of embryonic and adult stem cells with extendedand limited differentiation capacity. Genome Biol 2007;8(8): R163.
27. McIntyre AP, Bjornson BH. Human bone marrow stromal cell colonies: response to hydrocortisone and dependence on platelet derived growth factor. Exp Hematol 1986; 14(9): 833-9.
28. Kern S, Eichler H, Stoeve J, Klüter H, Bieback K. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 2006; 24(5): 1294-301.
29. Wexler SA, Donaldson C, Denning-Kendall P, Rice C, Bradley B, Hows JM. Adult bone marrow is a rich source of human mesenchymal'stem' cells but umbilical cord and mobilized adult blood are not. Br J Haematol 2003; 121(2): 368-74.
30. Altiok S, Xu M, Spiegelman BM. PPARgamma induces cell cycle with drawal: inhibition of E2F/DP DNA-binding activity via down regulation of PP2A. Genes Dev 1997; 11(15): 1987-98.
31. Aubin JE. Bone stem cells. J Cell Biochem Suppl 1998; 30-31: 73-82.
32. Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 2003; 92(8): 827-39.
33. Kalluri R. Basement membranes: structure, assembly and role intumour angiogenesis. Nat Rev Cancer 2003; 3(6): 422-33.
34. Ries C, Egea V, Karow M, Kolb H, Jochum M, Neth P. MMP-2,MT1-MMP, and TIMP-2 are essential for the invasive capacity of human mesenchymal stem cells: differential regulation by inflammatory cytokines. Blood 2007; 109(9): 4055-63.
35. Mitchell JB, McIntosh K, Zvonic S, et al. Immunopheno type of human adipose-derived cells: temporal changes in stromal associated and stem cell-associated markers. Stem Cells 2006;24(2): 376-85.
36. Jones RJ, Barber JP, Vala MS, et al. Assessment of aldehyde dehydrogenasein viable cells. Blood 1995; 85(10): 2742-6.
37. Fallon P, Gentry T, Balber AE, et al. Mobilized peripheral blood SSCloALDHbr cells have the phenotypic and functional properties of primitive haematopoietic cells and their number correlates with engraftment following autologous transplantation. Br J Haematol 2003; 122(1): 99-108.
38. Klyushnenkova E, Mosca JD, Zernetkina V, et al. T cell responsesto allogeneic human mesenchymal stem cells: immunogenicity, tolerance,and suppression. J Biomed Sci 2005; 12(1): 47-57.
39. Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005; 105(4): 1815-22.
40. Götherström C, Ringdén O, Westgren M, Tammik C, Le Blanc K. Immunomodulatory effects of human foetal liver-derived mesenchymalstem cells. Bone Marrow Transplant. 2003 Aug;32(3):265-72. Erratum in: Bone Marrow Transplant 2004; 33(11): 1167.
41. Puissant B, Barreau C, Bourin P, et al. Immunomodulatory effect of human adipose tissue-derived adult stem cells: comparison with bone marrow mesenchymal stem cells. Br J Haematol 2005;129(1): 118-29.
42. Di Nicola M, Carlo-Stella C, Magni M, et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 2002; 99(10): 3838-43.